Exchange: NASDAQ·Updated 10:00 AM EDT
PCSA logo

PCSA Processa Pharmaceuticals Inc

$2.01
$0.04
(1.95%)
Today
Reported EarningsAug 7
Mkt Cap$5.73M
Vol1,015.00

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
44

Bearish Sentiment

How do you feel about PCSA?

Advertisement|Remove ads.